Metoprolol Tartrate Tablets Recalled for Metal Wire Contamination
Aurobindo Pharma USA Inc. is recalling Metoprolol Tartrate 100 mg tablets due to the presence of metal wire found in at least one tablet. The FDA classified this as a Class II recall affecting 2,820 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a risk-of-harm hazard (metal wire contamination in a critical cardiac medication). Although no illnesses or injuries have been reported, the presence of a foreign object in a prescription drug that cannot be visually detected by patients creates significant potential for patient injury. Class II recalls require a score of at least 3, and the nature of this hazard (physical contamination in a heart medication) justifies a High severity rating.
Plain-English summary
Aurobindo Pharma USA Inc. is recalling Metoprolol Tartrate Tablets USP 100 mg (1,000-count bottles) distributed nationwide in the United States. The recall was initiated after product complaints identified the presence of metal wire in one tablet.
The affected product is Lot MJ1019025-A with an expiration date of 04/2022, distributed under NDC 65862-064-99. A total of 2,820 bottles have been distributed.
Metoprolol tartrate is a prescription medication used to treat heart conditions. Consumers who have this product should stop taking it and contact their pharmacist or healthcare provider. Patients should not discontinue their heart medication without medical guidance; they should consult their doctor about obtaining unaffected product or alternative treatment options.
Healthcare providers and pharmacists should check their inventory for the affected lot and quarantine any remaining stock. Consumers with questions can contact Aurobindo Pharma USA Inc. at 279 Princeton-Highstown Road East Windsor, NJ 08520.
The recalled product
- Product
- METOPROLOL TARTRATE (METOPROLOL TARTRATE)
- Brand
- METOPROLOL TARTRATE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Affected units
- 2,820
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: MJ1019025-A
- Exp. date 04/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL TARTRATE
- HighMetoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
FDA (Drugs) · 2024-06-05
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
Same manufacturer · Aurobindo Pharma USA Inc.
See all →- ModerateDicyclomine Hydrochloride Capsules Recalled for Empty Capsules
FDA (Drugs) · 2026-08-12
- ModerateAmazon Basic Care Acetaminophen 325 mg Tablets Recalled Due to Discoloration
FDA (Drugs) · 2025-06-25
- HighPrescription drug recall: Aurobindo Nebivolol tablets contain excess nitrosamine impurity
FDA (Drugs) · 2024-12-25
- HighPrescription Cinacalcet Tablets Recalled for N-Nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding FDA Safety Limit
FDA (Drugs) · 2024-12-11
Same hazard · metal contamination
See all →- HighRose and Shore Margarita Thin Crust Pizza Recalled for Metal Contamination
FDA (Food) · 2026-04-01
- HighWhite Oak Pastures Ground Beef Alerted for Possible Metal Contamination
USDA FSIS · 2026-03-23
- HighTestosterone 200 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone 87.5 mg pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05
- HighTestosterone and triamcinolone pellets recalled over potential metal particulate matter
FDA (Drugs) · 2025-11-05